Jennifer Richer-Mouchantat

University Of Colorado Denver

$2,679,313

Attributed

$3,322,916

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $656.4K · FY2009–25

$1M$750K$500K$250K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,322,916 · 3

By mechanism

R01$3,236,991 · 2

S10$85,925 · 1

Top collaborators

Min Yu2 shared

Most similar at University Of Colorado Denver

Same institution · by research overlap

Adam Lyon Green$1,905,394
Elizabeth Wellberg$1,612,619
Ross M Kedl$19,713,912
Lyndsey S Crump$90,865
James V Degregori$21,700,379

Others in their field

Top investigators on “Pathway Interactions”

David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
David R. Weir · University Of Michigan At Ann Arbor$129,316,139
Daniel Ernest Ford · Johns Hopkins University$108,075,637
David W Simpson · University Of Southern California$88,046,235
Charles D. Blanke · Oregon Health And Science University$86,571,896

Research focus

Pathway InteractionsAndrogen ReceptorTriple-Negative Invasive Breast CarcinomaNuclearAndrogensNeoplasm MetastasisResistanceEstrogen ReceptorsCellsTargeted TreatmentNovel TherapeuticsMalignant Breast NeoplasmExhibitsEstrogensMortalityErbb2 GeneAromatase InhibitorsIn VivoTumorCell NucleusCancer SubtypesAndrogen AntagonistsKnock-DownAffect